KATHY QUANDT

Controller at GT Biopharma, Inc. - Brisbane, CA, US

KATHY QUANDT's Contact Details
HQ
N/A
Location
Greater Minneapolis-St. Paul Area
Company
GT Biopharma, Inc.
KATHY QUANDT's Company Details
GT Biopharma, Inc. logo, GT Biopharma, Inc. contact details

GT Biopharma, Inc.

Brisbane, CA, US • 20 - 49 Employees
BioTech/Drugs

PURTHANOL has been at the forefront of research & development for solutions to the problems of CO2 emissions and deforestation, which the United Nations has determined are the two main contributors to global warming. Over the past several years we have advanced our technologies and proprietary knowledge past the proof of concept stage and are presently in the process of commencing large scale production of both our ethanol and biodiesel divisions.PURTHANOL'S ethanol production is highly profitable with a pre tax gross profit margin of 60% or more, in fact our feedstock is capable of generating up to three harvests per year in tropical locations while we have based our revenue projections on only two crops per year. PURTHANOL Biofuel's mission is to provide useful products from disposed commodities. Waste fryer grease converted into a clean burning replacement for diesel (biodiesel) will be the first of several recycling processes that produces biofuels. Expansion into the procurement of pure vegetable oil through the castor bean plant as a larger feedstock for biodiesel is our second biofuels project. Purthanol will manufacture biodiesel, a renewable fuel, from vegetable oils at various tropical locations. Around 75% of the biodiesel production costs account for the purchase of the vegetable oils or animal fat required, affecting greatly the margin profits for the producers. An R&D investment of 4 million dollars allows developing an in-house pre-industrial lipid production using glycerol which produced oil at a lower market price than wasted cooked oils. Our management team's skills sets cover all aspects of managing both the ethanol, biodiesel and now lipid production projects, including: science, technology, production, and management, marketing and sales. .

Immuno-oncology
Details about GT Biopharma, Inc.
Frequently Asked Questions about KATHY QUANDT
KATHY QUANDT currently works for GT Biopharma, Inc..
KATHY QUANDT's role at GT Biopharma, Inc. is Controller.
KATHY QUANDT's email address is ***@gtbiopharma.com. To view KATHY QUANDT's full email address, please signup to ConnectPlex.
KATHY QUANDT works in the BioTech/Drugs industry.
KATHY QUANDT's colleagues at GT Biopharma, Inc. are Rakesh Choubey, Julianne Feola, Bruce Wendel, Anthony Cataldo and others.
KATHY QUANDT's phone number is N/A
See more information about KATHY QUANDT